Postive Phase III Psoriasis Clinical Trial Results for Pfizer’s Xeljanz

Postive Phase III Psoriasis Clinical Trial Results for Pfizer's XeljanzPfizer have announced positive Phase III clinical trial results for their JAK inhibitor, Xeljanz (tofacitinib).

The results from data taken from two Phase III clinical trials provide additional support for the drug’s use to treat moderate to severe psoriasis.

Pfizer commented that the results from the trials show that both tofacitinib 10mg and 5mg tablets twice daily were superior to placebo in achieving a Physician’s Global Assessment response of “clear” or “almost clear”, in addition to at least a 75% reduction in Psoriasis Area and Severity Index (PASI75).

Continue reading

Clinical Professionals Launch 2015 / 2016 Pharmaceutical Salary Survey

Clinical Professionals Launch 2015 / 2016 Pharmaceutical Salary SurveyClinical Professionals have today launched their new life science salary survey for 2015 / 2016.

The survey will analyse salary and benefits for each sector of the European life science industry, and follows on from the success of our previous pharmaceutical salary surveys.

The salary survey is confidential and will only take a few minutes to complete.

The results of this year’s pharmaceutical salary survey will analysed alongside Clinical Professionals knowledge of the life sciences industry by the Marketing Communications team.  The results will then be compared to previous years’ results, and will be sent out to everyone who completes the survey and leaves their contact details.

Anyone working in the life sciences industry in Europe is invited to complete the survey; you don’t have to be registered with The Clinical Professionals Group.

To respond to the salary survey, and receive your copy of the results, please click here.

The Clinical Professionals Team

Clinical Professionals Achieve 3 Star Accreditation as a Sunday Times Top 100

Clinical Professionals Achieve 3 Star Accreditation as a Sunday Times Top 100Clinical Professionals are proud to announce that we have been ranked as one of the UK’s Top 100 best small companies to work for in 2015.

The company achieved a full 3 star accreditation, the top rating possible.  The award ceremony for the Best Small Companies took place last week, and was attended by a number of the Clinical Professionals team.

The Sunday Times Best Small Companies to Work for is decided by feedback from employees working for the company.  The Best Companies award is now in its 14th year, and was entered by over 1,000 businesses aiming to be recognised as an employer of choice.

2015 is the second year that The Clinical Professionals Group have entered the Best Companies award.  After being ranked as ‘One to Watch’ in 2014, its result for 2015, being given a full 3 star accreditation and Top 100 ranking, is an incredible result.

The outcome of the survey showed that Clinical Professionals scored highly on a number of different areas particularly around motivation, with employees responding very positively about the future of the company, opportunities for personal growth, management and organisational values.  Employees also fed back that they felt the company cares about making a positive difference, highlighting recent charity fundraising days.

Yvette Cleland, The Clinical Professionals Group’s CEO, commented:
“I am very proud to be part of such a successful Clinical Professionals Best Companies 2015and innovative business with such an incredible team of people.  People make a business.  To have such great feedback from all members of Clinical Professionals on how they feel about working within the business and their engagement and passion around our onward journey is incredibly exciting as they have been so instrumental in developing trusted partnerships with many clients and candidates in the UK and Europe.”

Sosei Acquires Heptares Therapeutics for $180 Million

Sosei Acquires Heptares Therapeutics for $180 MillionJapan’s Sosei have announced today that they have acquired Heptares Therapeutics, a UK based biotechnology company, in a deal that could be worth up to $400 million.

Heptares Therapeutics specialises in creating medicines targeting G protein-coupled receptors (GPCRs).  Sosei have agreed to pay $180 million of that upfront to gain access to Heptares’ GPCRs, a group of 375 receptors which are linked to a wide range of diseases, such as Alzheimer’s, ADHD, diabetes, schizophrenia and migraines.

Continue reading

Clinical Professionals Holds Heart Themed Day to Raise Money for The Silver Line Charity

Clinical Professionals Holds Heart Themed Day to Raise Money for The Silver Line CharityThe Clinical Professionals Group yesterday held their first event this year to raise money for their 2015 corporate charity, The Silver Line.

Clinical Professionals is proud to announce that its team raised over £250 for The Silver Line from their themed Valentine’s Day event.

Employees paid £1 to come to work wearing red clothing, or a £2 penalty if they forgot!  Cakes were baked by employees to be sold throughout the day.  All team members of Clinical Professionals could also donate £5 to pop a “Love Balloon” which were filled with prizes donated by the company such as additional days holiday and cash prizes.

The Silver Line Charity offer information, friendship and advice to older people within the UK, helping combat the widespread issue of loneliness within the older generation.  Many staff at Clinical Professionals in addition to fund raising events are also donating their time to be “friends of The Silver Line”.Employee popping a balloon at Clinical Professionals' Heart Themed Day

The Clinical Professionals Group’s CEO, Yvette Cleland, commented:
“Our choice of corporate charity is very important to us, there was a unanimous response to working with The Silver Line by our teams here at Clinical Professionals, which was amazing. We will be working hard this year to ensure we play a large role in raising funds for this amazing charity and Clinical Professionals will match the £250 raised by our staff contributing a total of £500.”

Genmab Announce Positive Results for Daratumumab to Treat Multiple Myeloma

Genmab Announce Positive Results for Daratumumab to Treat Multiple MyelomaGenmab and their partner Johnson & Johnson have today announced positive mid-stage clinical data on daratumumab for multiple myeloma.

The preliminary results are from a 124-patient Phase II client trial of daratumumab in double refractory multiple myeloma conducted by J&J’s Janssen Biotech unit.

The results show an overall response rate of 29.2% in the 16 mg/kg dosing group.  The median duration of response was 7.4 months.

Continue reading

Clinical Professionals to Support The Silver Line as their 2015 Corporate Charity

Clinical Professionals to Support The Silver Line as their 2015 Corporate CharityThe Clinical Professionals Group is delighted to announce that it has selected The Silver Line as its corporate charity for 2015.

Clinical Professionals’ feels that any charity selected as a corporate partner must have the full support of the employees.

Clinical Professionals CEO Yvette Cleland presented the work of The Silver Line as a contender for our 2015 charity at our Xmas event and the response from all staff was overwhelming in support of raising funds for The Silver Line.

Continue reading

BioInvent Signs Clinical Trials Agreement with UK Cancer Charities

BioInvent Signs Clinical Trials Agreement with UK Cancer CharitiesBioInvent International have announced that they have signed a clinical trial partnership with Cancer Research UK, Cancer Research Technology, and with Leukaemia and Lymphoma Research.

The clinical trial partnership will assess BioInvent’s experimental antibody, BI-1206, in reducing resistance to rituximab treatment in patients with certain blood cancers.

Continue reading

Clinical Professionals Referral Scheme

Clinical Professionals Referral SchemeClinical Professionals have launched a new online form, allowing people to easily refer a friend or colleague who may be looking for a new role within the life sciences industry.

The Clinical Professionals Group offers a generous referral scheme of £250 vouchers (or the European equivalent) for anyone who refers someone that we then go onto place in a role.*

As Europe’s leading independent life science recruitment company, The Clinical Professionals Group are constantly looking for ways to improve the job search experience for both candidates and clients.

If you know anyone who may be looking for a new role, with European experience working in the life sciences industry, please complete the form at: http://www.clinicalprofessionals.co.uk/referral-scheme.php

More Information

*subject to terms and conditions

Johnson & Johnson and Vectura to Collaborate on Asthma / COPD Agreement

Johnson & Johnson and Vectura to Collaborate on Asthma / COPD AgreementJohnson & Johnson and Vectura have announced a new partnership to develop anti-inflammatory therapies for asthma and chronic obstructive pulmonary disease (COPD).

Vectura, who are respiratory specialists, confirmed that the collaboration will primarily focus on a Phase II treatment, but may also include additional clinical-stage candidates.

Continue reading